IRIS Accounts Production v26.2.0.496 16274853 director 25.2.25 28.2.26 28.2.26 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh162748532025-02-24162748532026-02-28162748532025-02-252026-02-28162748532025-02-2416274853ns15:EnglandWales2025-02-252026-02-2816274853ns14:PoundSterling2025-02-252026-02-2816274853ns10:Director12025-02-252026-02-2816274853ns10:PrivateLimitedCompanyLtd2025-02-252026-02-2816274853ns10:SmallEntities2025-02-252026-02-2816274853ns10:AuditExempt-NoAccountantsReport2025-02-252026-02-2816274853ns10:SmallCompaniesRegimeForDirectorsReport2025-02-252026-02-2816274853ns10:SmallCompaniesRegimeForAccounts2025-02-252026-02-2816274853ns10:FullAccounts2025-02-252026-02-2816274853ns10:RegisteredOffice2025-02-252026-02-2816274853ns5:CurrentFinancialInstruments2026-02-2816274853ns5:RetainedEarningsAccumulatedLosses2026-02-2816274853ns5:WithinOneYearns5:CurrentFinancialInstruments2026-02-28
REGISTERED NUMBER: 16274853 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS

FOR THE PERIOD 25 FEBRUARY 2025 TO 28 FEBRUARY 2026

FOR

D'SOUZA MEDICAL LIMITED

D'SOUZA MEDICAL LIMITED (REGISTERED NUMBER: 16274853)

CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE PERIOD 25 FEBRUARY 2025 TO 28 FEBRUARY 2026










Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


D'SOUZA MEDICAL LIMITED

COMPANY INFORMATION
FOR THE PERIOD 25 FEBRUARY 2025 TO 28 FEBRUARY 2026







DIRECTOR: Dr C L D'Souza





REGISTERED OFFICE: Sequoia House
Hazeley Road
Twyford
Winchester
Hampshire
SO21 1PZ





REGISTERED NUMBER: 16274853 (England and Wales)





ACCOUNTANTS: Fraser CGA Winchester
12A Vicarage Farm
Business Park
Winchester Road
Fair Oak
Hampshire
SO50 7HD

D'SOUZA MEDICAL LIMITED (REGISTERED NUMBER: 16274853)

BALANCE SHEET
28 FEBRUARY 2026

Notes £   
CURRENT ASSETS
Debtors 4 3,529
Cash at bank 12,328
15,857
CREDITORS
Amounts falling due within one year 5 (5,773 )
NET CURRENT ASSETS 10,084
TOTAL ASSETS LESS CURRENT
LIABILITIES

10,084

RESERVES
Retained earnings 10,084
10,084

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the period ended 28 February 2026.

The members have not required the company to obtain an audit of its financial statements for the period ended 28 February 2026 in accordance with Section 476 of the Companies Act 2006.

The director acknowledges her responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the director and authorised for issue on 8 October 2026 and were signed by:





Dr C L D'Souza - Director


D'SOUZA MEDICAL LIMITED (REGISTERED NUMBER: 16274853)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE PERIOD 25 FEBRUARY 2025 TO 28 FEBRUARY 2026


1. STATUTORY INFORMATION

D'Souza Medical Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Taxation
Taxation for the period comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the period end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

3. EMPLOYEES AND DIRECTORS

The average number of employees during the period was 1 .

4. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Trade debtors 3,529

D'SOUZA MEDICAL LIMITED (REGISTERED NUMBER: 16274853)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE PERIOD 25 FEBRUARY 2025 TO 28 FEBRUARY 2026


5. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
£   
Taxation and social security 5,022
Other creditors 751
5,773